» Articles » PMID: 38782808

Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General Population

Overview
Publisher Springer
Specialty General Medicine
Date 2024 May 23
PMID 38782808
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The triglyceride-glucose index (TyG index), calculated as the logarithmic product of fasting triglyceride and glucose concentrations, is recognized as a simple marker of insulin resistance. However, the association between the TyG index and future decline of renal function remains unclear in the general population.

Objective: To investigate whether the TyG index was associated with future decline of renal function in the general population who had not progressed to chronic kidney disease stage G2.

Design: Retrospective longitudinal observational cohort study.

Participants: Individuals who received a population-based health checkup at JA Ehime Kouseiren Checkup Center from 2010 to 2019 (n = 134,007). Individuals without data of baseline fasting triglyceride or glucose levels, or baseline and follow-up data of estimated glomerular filtration rate (eGFR), or those with baseline eGFR < 60 mL/min/1.73 m were excluded.

Main Measures: Future renal function decline, defined as a ≥ 25% decrease in eGFR from baseline.

Key Results: Of 10,758 participants, 8,076 were classified into the low TyG index group (TyG index < 8.76, 1st to 3rd quartiles) and 2,682 into the high TyG index group (TyG index ≥ 8.76, 4th quartile). The mean follow-up period was 37.8 ± 23.6 months. The incidence rates of renal function decline were 0.31 and 0.69 per 100 person-years in the low and high TyG index groups, respectively. In multivariate Cox proportional hazard models, high TyG index was significantly associated with future renal function decline (hazard ratio 2.25, 95% CI 1.40-3.60). This association was consistent across subgroups stratified by age, sex, body mass index, baseline eGFR, and diagnosed hypertension, diabetes, or dyslipidemia.

Conclusion: In the general population, high TyG index was associated with future renal function decline. The TyG index may be useful in identifying individuals at high risk for future renal function decline in the setting of health checkups.

Citing Articles

Higher triglyceride-glucose index is associated with severe proteinuria and decreased renal function in patients with primary membranous nephropathy.

Gao Y, Wang Z, Deng Z, Wang Y BMC Nephrol. 2025; 26(1):114.

PMID: 40045226 PMC: 11884001. DOI: 10.1186/s12882-025-04022-5.


Associations between non-insulin-based insulin resistance indices and diabetic nephropathy in patients with diabetes mellitus in US adults: a cross-sectional study of NHANES 1999-2018.

Zhang F, Han Y, Mao Y, Li W Front Endocrinol (Lausanne). 2024; 15:1458521.

PMID: 39720248 PMC: 11666371. DOI: 10.3389/fendo.2024.1458521.


Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study.

Liu L, Sun H, Yi L, Wang G, Zou Y BMC Cardiovasc Disord. 2024; 24(1):723.

PMID: 39707186 PMC: 11661009. DOI: 10.1186/s12872-024-04407-8.


Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.

Luo P, Li D, Guo Y, Meng X, Kan R, Pan L Cardiovasc Diabetol. 2024; 23(1):401.

PMID: 39511523 PMC: 11546320. DOI: 10.1186/s12933-024-02496-5.


Association Between Triglyceride Glucose Index and Chronic Kidney Disease in Normal-Weight Chinese Adults With Hypertension.

Yu C, Zhou W, Zhou X, Zhu L, Wang T, Bao H J Clin Hypertens (Greenwich). 2024; 26(12):1433-1440.

PMID: 39400503 PMC: 11654844. DOI: 10.1111/jch.14913.

References
1.
Skrha J, Soupal J, Skrha Jr J, Prazny M . Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016; 17(1):103-10. DOI: 10.1007/s11154-016-9347-2. View

2.
Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

3.
Castro B, Foresto-Neto O, Saraiva-Camara N, Sanders-Pinheiro H . Renal lipotoxicity: Insights from experimental models. Clin Exp Pharmacol Physiol. 2021; 48(12):1579-1588. DOI: 10.1111/1440-1681.13556. View

4.
Tahapary D, Pratisthita L, Fitri N, Marcella C, Wafa S, Kurniawan F . Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022; 16(8):102581. DOI: 10.1016/j.dsx.2022.102581. View

5.
Lee D, Lee E, Kim J, Park S, Park C, Oh K . Predictive Value of Triglyceride Glucose Index for the Risk of Incident Diabetes: A 4-Year Retrospective Longitudinal Study. PLoS One. 2016; 11(9):e0163465. PMC: 5040250. DOI: 10.1371/journal.pone.0163465. View